Found 7 matching trials
MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104) PHASE3 The phase III clinical trial examines the efficacy, safety, and tolerabilit...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus PHASE4 This study is planned to evaluate if linagliptin can improve insulin sensit...
Show More Location
Postgraduate Institute of Medical Education & Research
Learn More & Join Trial
Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015) PHASE3 This study will examine the safety and efficacy of the addition of omarigli...
Show More Location
Multiple Locations
Learn More & Join Trial
Japanese P III vs Voglibose and Placebo PHASE3 The objective of the current study is to investigate the efficacy, safety a...
Show More Location
1218.23.05 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan PHASE2 The purpose of this study was to evaluate the dose-response relationships o...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease. NA The purpose of this study is to determine whether therapeutic intervention ...
Show More Location
Peking University First Hospital
Learn More & Join Trial
Efficacy and Safety of Alogliptin Used in Combination With Ξ±-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan PHASE2 The purpose of this study was to evaluate the efficacy and safety of alogli...
Show More Location
Multiple Locations
Learn More & Join Trial